Innovent Announces Completion of First Participant Dosed in the Seventh Phase 3 Clinical Trial (GLORY-OSA) of Mazdutide in China
SAN FRANCISCO and SUZHOU, China, June 16, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels
CLEVELAND, June 13, 2025 /PRNewswire/ -- Primary Investigator, Bernardo Cortese MD, proudly announces the successful completion of patient enrollment in the TRANSFORM II randomized controlled trial (RCT). This pivotal study aims to evaluate the...
ZKH Group Limited Announces New Share Repurchase Program
SHANGHAI, June 13, 2025 /PRNewswire/ -- ZKH Group Limited ("ZKH" or the "Company") (NYSE: ZKH), a leading maintenance, repair and operations ("MRO") procurement service platform in China, today announced that its board of directors has authorized a...
Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine
CHENGDU, China, June 12, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) today announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of...
XtalPi Announces Strategic Acquisition of Liverpool ChiroChem (LCC), Unlocking Unprecedented Power in Chemical Space Exploration
CAMBRIDGE, Mass. and LIVERPOOL, United Kingdom, June 13, 2025 /PRNewswire/ -- XtalPi, a leading life sciences and new materials R&D platform powered by quantum physics, AI and robotics, today announced its acquisition of Liverpool ChiroChem...
Innovent to Present Multiple R&D Results of General Biomedicine Pipeline at the ADA's 85th Scientific Sessions
SAN FRANCISCO and SUZHOU, China, June 13, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
BEST SPAC I Acquisition Corp. Announces Pricing of $55 Million Initial Public Offering
HONG KONG, June 13, 2025 /PRNewswire/ -- BEST SPAC I Acquisition Corp. (the "Company"), a blank check company incorporated as a British Virgin Islands business company formed for the purpose of effecting a merger, share exchange, asset acquisition,...
Epicsoft Asia Pte. Ltd. Announces Intention to Exercise Right of Compulsory Acquisition in relation to the Offer for Ban Leong Technologies Limited and Subsequent Delisting
As at 6.00 p.m. (Singapore time) on 12 June 2025, the Offeror owns, controls, or has agreed to acquire an aggregate of 100,167,499 Shares, representing approximately 92.92% of the total number of issued Shares of Ban Leong Technologies Limited. With...
Databricks Announces Strategic AI Partnership with Google Cloud to Bring Gemini Models Natively to the Data Intelligence Platform
SAN FRANCISCO, June 12, 2025 /PRNewswire/ -- Databricks, the Data and AI company, today announced a new strategic product partnership with Google Cloud to make the latest Gemini models available as native products within the Databricks Data...
Solace Announces Paul Fitzpatrick as Chief Marketing and Business Development Officer
OTTAWA, ON, June 12, 2025 /PRNewswire/ -- Solace, the leader in powering real-time, event-driven integration for the agentic age, announced today that Paul Fitzpatrick has joined the company as its new Chief Marketing and Business Development...